86 results
Page 4 of 5
6-K
EX-99.1
j0bhc8kghj7srcaq
29 Mar 19
Current report (foreign)
6:16am
6-K
EX-99.1
pi6htu0
29 Mar 19
Current report (foreign)
6:02am
6-K
EX-99.1
ykehifx dl
29 Mar 19
Current report (foreign)
6:00am
6-K
EX-99.1
vchyghhiu4p n9
7 Jan 19
Current report (foreign)
7:29am
6-K
EX-99.1
e4hn2fjc qnnz7p
18 Dec 18
Current report (foreign)
6:07am
6-K
EX-99.1
v5xm0tudh125xkm
28 Nov 18
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
6:00am
6-K
EX-99.2
afgy hv6tjlzl
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
6-K
EX-99.1
dbeee68yi7qqgfcdj
23 Oct 18
Positive Trial Results with Filgotinib In Psoriatic Arthritis and Ankylosing Spondylitis Both Published In the Lancet
7:59am
6-K
EX-99.1
3r5bqvsnf9lw ev1i0i
22 Oct 18
Phase 3 Data on Filgotinib In Biologic-experienced Rheumatoid Arthritis to Be Presented at 2018 Acr/arhp Annual Meeting
6:05am
6-K
EX-99.1
zq3x5cgbugstdd
24 Sep 18
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients
6:05am
424B5
82p6awuaqpm5vk
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
9lwz2t8itbqdfc tq
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.1
e63a2qbzr 5f
27 Jun 18
Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients
6:01am
6-K
EX-99.1
ecuh1dn3liy1fddv1
22 May 18
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
6:00am
6-K
EX-99.2
nnk 03fhtuvhea399f
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
6-K
EX-3.1
ewev2s05xvph33 jt1
18 Apr 17
Galapagos announces launch of proposed public offering
12:00am